Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Pinellia pedatisecta agglutinin targets drug resistant K562/ADR leukemia cells through binding with sarcolemmal membrane associated protein and enhancing macrophage phagocytosis.

Chen K, Yang X, Wu L, Yu M, Li X, Li N, Wang S, Li G.

PLoS One. 2013 Sep 3;8(9):e74363. doi: 10.1371/journal.pone.0074363. eCollection 2013.

2.

Knockdown of PRAME enhances adriamycin-induced apoptosis in chronic myeloid leukemia cells.

Yan H, Zhao RM, Wang ZJ, Zhao FR, Wang SL.

Eur Rev Med Pharmacol Sci. 2015 Dec;19(24):4827-34.

3.

Mannose-exposing myeloid leukemia cells detected by the sCAR-PPA fusion protein.

Li GC, Li N, Zhang YH, Li X, Wang YG, Liu XY, Qian WB, Liu XC.

Int J Hematol. 2009 Jun;89(5):611-7. doi: 10.1007/s12185-009-0308-3. Epub 2009 Apr 18.

PMID:
19377843
4.

Involvement of annexin A1 in multidrug resistance of K562/ADR cells identified by the proteomic study.

Zhu F, Wang Y, Zeng S, Fu X, Wang L, Cao J.

OMICS. 2009 Dec;13(6):467-76. doi: 10.1089/omi.2009.0046.

PMID:
20001861
5.
7.
8.

Imatinib mesylate (STI571) abrogates the resistance to doxorubicin in human K562 chronic myeloid leukemia cells by inhibition of BCR/ABL kinase-mediated DNA repair.

Majsterek I, Sliwinski T, Poplawski T, Pytel D, Kowalski M, Slupianek A, Skorski T, Blasiak J.

Mutat Res. 2006 Jan 31;603(1):74-82. Epub 2006 Jan 4.

PMID:
16388976
9.

Tetrandrine citrate eliminates imatinib-resistant chronic myeloid leukemia cells in vitro and in vivo by inhibiting Bcr-Abl/β-catenin axis.

Xu XH, Gan YC, Xu GB, Chen T, Zhou H, Tang JF, Gu Y, Xu F, Xie YY, Zhao XY, Xu RZ.

J Zhejiang Univ Sci B. 2012 Nov;13(11):867-74. doi: 10.1631/jzus.B1200021.

10.

[Development of a K562 multidrug-resistant cell line and study on proteins with altered expression].

Wang Y, Cao J, Zeng S.

Shi Yan Sheng Wu Xue Bao. 2003 Oct;36(5):342-6. Chinese.

PMID:
14724945
11.

A proteomic investigation into adriamycin chemo-resistance of human leukemia K562 cells.

Peng X, Gong F, Xie G, Zhao Y, Tang M, Yu L, Tong A.

Mol Cell Biochem. 2011 May;351(1-2):233-41. doi: 10.1007/s11010-011-0730-8. Epub 2011 Jan 18.

PMID:
21243406
12.

Glycomic alterations are associated with multidrug resistance in human leukemia.

Zhang Z, Zhao Y, Jiang L, Miao X, Zhou H, Jia L.

Int J Biochem Cell Biol. 2012 Aug;44(8):1244-53. doi: 10.1016/j.biocel.2012.04.026. Epub 2012 May 11.

PMID:
22579717
13.

Sonic hedgehog signaling regulates Bcr-Abl expression in human chronic myeloid leukemia cells.

Liao HF, Su YC, Zheng ZY, Jhih Cai C, Hou MH, Chao KS, Chen YJ.

Biomed Pharmacother. 2012 Jul;66(5):378-83. doi: 10.1016/j.biopha.2011.12.008. Epub 2012 Feb 16.

PMID:
22397755
14.

Reversal of the resistance to STI571 in human chronic myelogenous leukemia K562 cells.

Mukai M, Che XF, Furukawa T, Sumizawa T, Aoki S, Ren XQ, Haraguchi M, Sugimoto Y, Kobayashi M, Takamatsu H, Akiyama S.

Cancer Sci. 2003 Jun;94(6):557-63.

15.

Characteristics of dasatinib- and imatinib-resistant chronic myelogenous leukemia cells.

Okabe S, Tauchi T, Ohyashiki K.

Clin Cancer Res. 2008 Oct 1;14(19):6181-6. doi: 10.1158/1078-0432.CCR-08-0461.

16.

Tyrosine kinase inhibitor resistance in chronic myeloid leukemia cell lines: investigating resistance pathways.

Tang C, Schafranek L, Watkins DB, Parker WT, Moore S, Prime JA, White DL, Hughes TP.

Leuk Lymphoma. 2011 Nov;52(11):2139-47. doi: 10.3109/10428194.2011.591013. Epub 2011 Jun 30.

PMID:
21718141
17.

Anti-tumor activity of emodin against human chronic myelocytic leukemia K562 cell lines in vitro and in vivo.

Chun-Guang W, Jun-Qing Y, Bei-Zhong L, Dan-Ting J, Chong W, Liang Z, Dan Z, Yan W.

Eur J Pharmacol. 2010 Feb 10;627(1-3):33-41. doi: 10.1016/j.ejphar.2009.10.035. Epub 2009 Oct 24.

PMID:
19857484
18.

Targeting glucosylceramide synthase sensitizes imatinib-resistant chronic myeloid leukemia cells via endogenous ceramide accumulation.

Baran Y, Bielawski J, Gunduz U, Ogretmen B.

J Cancer Res Clin Oncol. 2011 Oct;137(10):1535-44. doi: 10.1007/s00432-011-1016-y. Epub 2011 Aug 11.

PMID:
21833718
19.
20.

Supplemental Content

Support Center